Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Amicus Brief
Dec 2, 2020
| Jeff Francer
U.S. v. Arthrex
Blog
Nov 25, 2020
| Erica Klinger
Health Care Savings, State by State
Press Release
Nov 20, 2020
| Rachel Schwartz
AAM Statement on Trump’s Drug Pricing Ruling – Rebates and Most Favored Nation Model
Press Release
Nov 11, 2020
| Rachel Schwartz
AAM Statement on 2020 Election
Blog
Nov 2, 2020
| Jewel Smith
Member Spotlight: Sandoz
Blog
Oct 29, 2020
| Erica Klinger
Top 10 Ways to Commemorate 10 Years of Biosimilars in the U.S.
Blog
Oct 23, 2020
| Bob Billings
Thank you, Mike Puskar
Blog
Oct 20, 2020
| Sara Skubikowski
Adding up the Generic Savings for Americans with Cancer and Other Conditions
Blog
Oct 15, 2020
| Erica Klinger
Jeni Got Her Life Back, Thanks to a Biosimilar
Video
Oct 8, 2020
| Erica Klinger
Jeni's Story — Savings from Biosimilar Medicines
Press Release
Oct 7, 2020
| Rachel Schwartz
AAM Statement on the Introduction of the Protecting Access to Affordable Medicines Act of 2020
Report
Oct 6, 2020
| Erica Klinger
White Paper: Nitrosamines — An Industry Position Paper Based on Risk
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action